MK0633

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

AsthmaAtherosclerosis

Phase 1

MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)

CompletedNCT00768170

Merck Sharp & Dohme LLCAsthma

Start: 2008-09-30End: 2009-05-31Updated: 2015-07-03

Phase 2

The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

TerminatedNCT00404313

Merck Sharp & Dohme LLCAsthma

Start: 2008-01-31End: 2009-06-30Updated: 2015-10-20

The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

CompletedNCT00421278

Merck Sharp & Dohme LLCAtherosclerosis

Start: 2006-11-30End: 2007-01-31Updated: 2016-01-22